Display:
Providers:
Bionano Genomics, Inc. is a genomics company, which provides optical genome mapping (OGM) for genome analysis. The Company offers diagnostic services to physicians specializing in medical management for individuals with genetic conditions, such as pediatric neurodevelopmental disorders, including autism spectrum disorders. It markets and sells the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation. Its Lineagen business provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. Through its BioDiscovery business, it offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants and absence of heterozygosity across the genome in one consolidated view.
|
|
|
|
|
September 22, 2023 | ||
---|---|---|
September 21, 2023 | ||
September 14, 2023 | ||
September 06, 2023 | ||
August 30, 2023 | ||
August 28, 2023 | ||
August 21, 2023 | ||
August 16, 2023 | ||
August 14, 2023 | ||
August 11, 2023 | ||
August 09, 2023 | ||
August 04, 2023 | ||
Bionano Genomics Announces Reverse Stock Split(Globe Newswire) | ||
August 02, 2023 | ||
July 31, 2023 | ||
July 27, 2023 | ||
June 29, 2023 | ||
Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.
Options are not suitable for all investors as the special risks inherent to options trading may
expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.
"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.
Copyright © 2023. All rights reserved.